Pembrolizumab (MK-3475) in combination with lenalidomide and low-dose dexamethasone for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-023
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P160
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mateos, Maria-Victoria
Siegel, David
Shah, Jatin J
Reece, Donna
Avigan, David
Orlowski, Robert
Ge, Yang
Balakumaran, Arun
Marinello, Patricia
Miguel, Jesus San
Article History
First Online: 4 November 2015